{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T02:33:45Z","timestamp":1788921225122,"version":"build-2803163510"},"reference-count":24,"publisher":"Elsevier BV","issue":"23-24","license":[{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1016\/j.vaccine.2004.01.060","type":"journal-article","created":{"date-parts":[[2004,3,5]],"date-time":"2004-03-05T12:28:03Z","timestamp":1078489683000},"page":"3187-3194","source":"Crossref","is-referenced-by-count":29,"title":["Long-lasting specific antibodies against CETP induced by subcutaneous and mucosal administration of a 26-amino acid CETP epitope carried by heat shock protein 65 kDa in the absence of adjuvants"],"prefix":"10.1016","volume":"22","author":[{"given":"Qi","family":"Gaofu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mao","family":"Dan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu","family":"Jie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongping","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rouel S","family":"Roque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Jingjing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2004.01.060_BIB1","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1002\/eji.1830220606","article-title":"Mycobacterial heat-shock proteins as carrier molecules. II: The use of the 70-kDa mycobacterial heat-shock protein as carrier for conjugated vaccines can circumvent the need for adjuvants and Bacillus Calmette Guerin priming","volume":"22","author":"Barrios","year":"1992","journal-title":"Eur J Immunol."},{"key":"10.1016\/j.vaccine.2004.01.060_BIB2","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1365-2249.1993.tb08189.x","article-title":"Successful primate immunization with peptides conjugated to purified protein derivative or mycobacterial heat shock proteins in the absence of adjuvants","volume":"93","author":"Perraut","year":"1993","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.vaccine.2004.01.060_BIB3","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1365-2249.1994.tb06129.x","article-title":"Specificity of antibodies induced after immunization of mice with the mycobacterial heat shock protein of 65 kDa","volume":"98","author":"Barrios","year":"1994","journal-title":"Clin Exp Immunol."},{"key":"10.1016\/j.vaccine.2004.01.060_BIB4","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0022-2275(20)36957-1","article-title":"Plasma cholesteryl ester transfer protein","volume":"34","author":"Tall","year":"1993","journal-title":"J Lipid Res."},{"key":"10.1016\/j.vaccine.2004.01.060_BIB5","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1440-1681.1994.tb02569.x","article-title":"Cholesteryl ester transfer protein: its role in plasma lipid transport","volume":"21","author":"Barter","year":"1994","journal-title":"Clin Exp Pharmacol Physiol."},{"key":"10.1016\/j.vaccine.2004.01.060_BIB6","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1365-2796.1995.tb01133.x","article-title":"Plasma cholesteryl ester transfer protein and high-density lipoproteins: new insights from molecular genetic studies","volume":"237","author":"Tall","year":"1995","journal-title":"J Int Med."},{"key":"10.1016\/j.vaccine.2004.01.060_BIB7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1567-5688(03)00006-0","article-title":"HDL in atherosclerosis: actor or bystander?","volume":"4","author":"Asztalos","year":"2003","journal-title":"Atheroscler Suppl."},{"key":"10.1016\/j.vaccine.2004.01.060_BIB8","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1172\/JCI114132","article-title":"Monoclonal antibody inhibition of cholesteryl ester transfer protein activity in the rabbit. Effects on lipoprotein composition and high density lipoprotein cholesteryl ester metabolism","volume":"84","author":"Whitlock","year":"1989","journal-title":"J Clin Invest."},{"key":"10.1016\/j.vaccine.2004.01.060_BIB9","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1161\/01.ATV.20.9.2106","article-title":"Vaccine-induced antibodies inhibit CETP activity in vivo and reduce aortic lesions in a rabbit model of atherosclerosis","volume":"20","author":"Rittershaus","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"10.1016\/j.vaccine.2004.01.060_BIB10","doi-asserted-by":"crossref","first-page":"5033","DOI":"10.1074\/jbc.273.9.5033","article-title":"Effect of antisense oligonucleotides against cholesteryl ester transfer protein on the development of atherosclerosis in cholesterol-fed rabbits","volume":"273","author":"Sugano","year":"1998","journal-title":"J Biol Chem."},{"key":"10.1016\/j.vaccine.2004.01.060_BIB11","doi-asserted-by":"crossref","first-page":"14318","DOI":"10.1016\/S0021-9258(18)71680-3","article-title":"Mechanism of cholesteryl ester transfer protein inhibition by a neutralizing monoclonal antibody and mapping of the monoclonal antibody epitope","volume":"264","author":"Swenson","year":"1989","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2004.01.060_BIB12","first-page":"752","article-title":"Human Muller cells express VEGF183, a novel spliced variant of vascular endothelial growth factor","volume":"40","author":"Jingjing","year":"1999","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"10.1016\/j.vaccine.2004.01.060_BIB13","first-page":"518","article-title":"CD4 + T-cell responses to recombinant hsp65 and hsp18 of M. leprae and their trypsin-digested fragments in leprosy: diversity in HLA-DR restriction","volume":"63","author":"Mitra","year":"1995","journal-title":"Int J Lepr Other Mycobact Dis."},{"key":"10.1016\/j.vaccine.2004.01.060_BIB14","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1379\/1466-1268(2000)005<0401:IOAHPT>2.0.CO;2","article-title":"Immunotherapy of a human papillomavirus type 16 E7-expressing tumor by administration of fusion protein comprised of Mycobacterium bovis BCG Hsp65 and HPV16 E7A","volume":"5","author":"Chu","year":"2000","journal-title":"Cell Stress Chaperones."},{"key":"10.1016\/j.vaccine.2004.01.060_BIB15","doi-asserted-by":"crossref","first-page":"7400","DOI":"10.1021\/bi011999l","article-title":"The Mycobacterium leprae hsp65 displays proteolytic activity. Mutagenesis studies indicate that the M. leprae hsp65 proteolytic activity is catalytically related to the HslVU protease","volume":"41","author":"Portaro","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.vaccine.2004.01.060_BIB16","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1128\/IAI.55.6.1466-1475.1987","article-title":"Characterization, sequence determination, and immunogenicity of a 64-kilodalton protein of Mycobacterium bovis BCG expressed in Escherichia coli K-12","volume":"55","author":"Thole","year":"1987","journal-title":"Infect Immunol."},{"key":"10.1016\/j.vaccine.2004.01.060_BIB17","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1095\/biolreprod58.3.794","article-title":"Immune response to immunization with sperm antigens in the macaque oviduct","volume":"58","author":"Lea","year":"1998","journal-title":"Biol Reprod."},{"key":"10.1016\/j.vaccine.2004.01.060_BIB18","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1093\/humrep\/12.12.2664","article-title":"Immunoreactivity and in-vitro effect on human sperm\u2013egg binding of antibodies against peptides corresponding to bonnet monkey zona pellucida-3 glycoprotein","volume":"12","author":"Afzalpurkar","year":"1997","journal-title":"Hum Reprod."},{"key":"10.1016\/j.vaccine.2004.01.060_BIB19","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1365-3083.1992.tb01635.x","article-title":"Anti-LHRH and anti-pituitary gonadotropin vaccines: their development and clinical applications","volume":"11","author":"Thau","year":"1992","journal-title":"Scand J Immunol Suppl."},{"key":"10.1016\/j.vaccine.2004.01.060_BIB20","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/bmb\/62.1.175","article-title":"Life-style vaccines","volume":"62","author":"Mettens","year":"2002","journal-title":"Br Med Bull."},{"key":"10.1016\/j.vaccine.2004.01.060_BIB21","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S1535-6108(02)00208-8","article-title":"Vaccination against tumor neovascularization: Promise and reality","volume":"2","author":"Rafii","year":"2002","journal-title":"Cancer Cell."},{"key":"10.1016\/j.vaccine.2004.01.060_BIB22","doi-asserted-by":"crossref","first-page":"11545","DOI":"10.1073\/pnas.191112198","article-title":"Immunogene therapy of tumors with vaccine based on Xenopus homologous vascular endothelial growth factor as a model antigen","volume":"98","author":"Wei","year":"2001","journal-title":"Proc Natl Acad Sci USA."},{"key":"10.1016\/j.vaccine.2004.01.060_BIB23","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/nm1202-794","article-title":"A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth","volume":"8","author":"Niethammer","year":"2002","journal-title":"Nat Med."},{"key":"10.1016\/j.vaccine.2004.01.060_BIB24","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1182\/blood-2002-12-3772","article-title":"Immunotherapy of tumors with vaccine based on quail homologous vascular endothelial growth factor receptor-2A","volume":"102","author":"Liu","year":"2003","journal-title":"Blood."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X04001501?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X04001501?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T01:04:52Z","timestamp":1623719092000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X04001501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":24,"journal-issue":{"issue":"23-24","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["S0264410X04001501"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2004.01.060","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,8]]}}}